Authors: Fevig, JM Pinto, DJ Han, Q Quan, ML Pruitt, JR Jacobson, IC Galemmo, RA Wang, SA Orwat, MJ Bostrom, LL Knabb, RM Wong, PC Lam, PYS Wexler, RR

Citation: Jm. Fevig et al., Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core, BIOORG MED, 11(5), 2001, pp. 641-645

Authors: Pinto, DJP Orwat, MJ Wang, SG Fevig, JM Quan, ML Amparo, E Cacciola, J Rossi, KA Alexander, RS Smallwood, AM Luettgen, JM Liang, L Aungst, BJ Wright, MR Knabb, RM Wong, PC Wexler, RR Lam, PYS

Citation: Djp. Pinto et al., Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2 '- (methylsulfonyl)-[1,1 '-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa, J MED CHEM, 44(4), 2001, pp. 566-578

Authors: Pinto, DJP Batt, DG Pitts, WJ Petraitis, JJ Orwat, MJ Wang, SG Jetter, JW Sherk, SR Houghton, GC Copeland, RA Covington, MB Trzaskos, JM Magolda, RL

Citation: Djp. Pinto et al., Terphenyl cyclooxygenase-2 (COX-2) inhibitors: Optimization of the centralring and o-biphenyl analogs, BIOORG MED, 9(7), 1999, pp. 919-924

Authors: Olson, RE Sielecki, TM Wityak, J Pinto, DJ Batt, DG Frietze, WE Liu, J Tobin, AE Orwat, MJ Di Meo, SV Houghton, GC Lalka, GK Mousa, SA Racanelli, AL Hausner, EA Kapil, RP Rabel, HR Thoolen, MJ Reilly, TM Anderson, PS Wexler, RR

Citation: Re. Olson et al., Orally active isoxazoline glycoprotein IIb/IIIa antagonists with extended duration of action, J MED CHEM, 42(7), 1999, pp. 1178-1192